Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms

Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms

Abstract Several randomized controlled trials have demonstrated the benefits of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on ischemic stroke in patients with diabetes. In this review, we summarize and discuss the potential mechanisms of stroke protection by GLP-1RAs. GLP-1RAs exert multip...

Full description

Bibliographic Details
Main Authors: Bruno Vergès, Victor Aboyans, Denis Angoulvant, Pierre Boutouyrie, Bertrand Cariou, Fabien Hyafil, Kamel Mohammedi, Pierre Amarenco
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Cardiovascular Diabetology
Subjects:
Stroke
Glucagon-like peptide-1 receptor agonists
GLP-1
Neuroprotection
Mechanisms
Online Access:https://doi.org/10.1186/s12933-022-01686-3

Internet

https://doi.org/10.1186/s12933-022-01686-3

Similar Items